A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication
Publication
, Conference
Weiss, N; Nikoi, S; Rosen, Y; Patel, MR
Published in: CIRCULATION
December 18, 2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E769 / E770
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Weiss, N., Nikoi, S., Rosen, Y., & Patel, M. R. (2018). A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication. In CIRCULATION (Vol. 138, pp. E769–E770). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Weiss, Norbert, Sigrid Nikoi, Yael Rosen, and Manesh R. Patel. “A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication.” In CIRCULATION, 138:E769–70. LIPPINCOTT WILLIAMS & WILKINS, 2018.
Weiss N, Nikoi S, Rosen Y, Patel MR. A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E769–70.
Weiss, Norbert, et al. “A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication.” CIRCULATION, vol. 138, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2018, pp. E769–70.
Weiss N, Nikoi S, Rosen Y, Patel MR. A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogenic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E769–E770.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E769 / E770
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology